chr1-147187025-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001461.4(FMO5):c.1477G>A(p.Asp493Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00077 in 1,614,174 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001461.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FMO5 | NM_001461.4 | c.1477G>A | p.Asp493Asn | missense_variant | 9/9 | ENST00000254090.9 | NP_001452.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FMO5 | ENST00000254090.9 | c.1477G>A | p.Asp493Asn | missense_variant | 9/9 | 1 | NM_001461.4 | ENSP00000254090.4 |
Frequencies
GnomAD3 genomes AF: 0.000775 AC: 118AN: 152198Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000851 AC: 214AN: 251396Hom.: 0 AF XY: 0.000927 AC XY: 126AN XY: 135870
GnomAD4 exome AF: 0.000770 AC: 1125AN: 1461858Hom.: 0 Cov.: 32 AF XY: 0.000800 AC XY: 582AN XY: 727230
GnomAD4 genome AF: 0.000775 AC: 118AN: 152316Hom.: 1 Cov.: 32 AF XY: 0.000765 AC XY: 57AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.1477G>A (p.D493N) alteration is located in exon 9 (coding exon 8) of the FMO5 gene. This alteration results from a G to A substitution at nucleotide position 1477, causing the aspartic acid (D) at amino acid position 493 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at